Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Belluna Ord Shs BLUNF

BELLUNA CO.,LTD. is a Japan-based company mainly engaged in the mail order business. The Company operates through seven business segments. General Mail Order segment is involved in the sale of lifestyle related products such as clothing, household goods and furniture, as well as the provision of the related business. Specialty Mail Order segment is involved in the sale of single items, as well... see more

Showcase News Releases

Showcase news

Promino Nutritional Sciences Inc.
Promino Nutritional Sciences Inc.: New Clinical Study Confirms A 3.6 gram Serving of Rejuvenate Muscle Activator(TM) Produces the Equivalent Muscle Protein Synthesis as 40 grams of Whey Protein
Africa Oil Corp.
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index
NurExone Biologic Inc.
NurExone Demonstrates Extended Therapeutic Window of ExoPTEN Post Spinal-Cord Injury in Preclinical Study

More Showcase News Releases »